Leadless Pacemaker Atrial Event Detection via Multi-Modal Sensing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current leadless cardiac pacemakers face challenges in accurately detecting atrial events within the heart, which are crucial for synchronizing ventricular pacing and optimizing cardiac therapy, especially in conditions like bradycardia and cardiac resynchronization therapy, due to limited sensing capabilities and reliance on atrial signals that may be difficult to detect within the ventricle.
Innovation Solution
A leadless cardiac pacemaker system that includes a control module capable of dynamically selecting measurement modules based on signal-to-noise ratio and priority, using signal averaging, and adjusting pacing modes to identify atrial events through a combination of pressure, acoustic, and electrogram measurements, allowing for ventricular pacing therapy delivery based on identified atrial activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If a leadless cardiac pacemaker is implanted in the ventricle to deliver pacing therapy, then the device complexity is reduced and ease of manufacture is improved, but the ability to accurately detect atrial events is worsened due to limited sensing capabilities in the ventricular location
Solution Approach 1:
The leadless ventricular pacemaker is designed to perform multiple functions: delivering ventricular pacing therapy and detecting atrial events. The device incorporates multiple sensing modalities (pressure sensors, accelerometers, electrogram sensors) that enable it to detect both ventricular and atrial physiological parameters, making a single device capable of functions previously requiring separate devices
Solution Approach 2:
The patent uses intermediary physiological signals that can be detected from the ventricle to infer atrial events. Specifically, it detects ventricular filling patterns, pressure changes, and mechanical movements that are caused by or correlated with atrial contraction, using these as mediators to indirectly sense atrial activity without direct atrial contact
2Measurement precision
If the pacemaker relies on direct atrial signals for detecting atrial events, then the measurement precision is improved, but the ease of operation is worsened due to difficulty in detecting atrial signals from the ventricular location
Solution Approach 1:
The patent replaces direct electrical signal sensing with mechanical and pressure-based sensing. Instead of using electrogram sensors to directly detect atrial electrical activity, the device uses pressure sensors to detect ventricular filling pressure changes and accelerometers to detect mechanical movements caused by atrial contraction, substituting electrical sensing with mechanical sensing modalities
Solution Approach 2:
The patent transitions from detecting electrical signals in one dimension to detecting mechanical and pressure parameters in different dimensions. By measuring pressure changes, acceleration, and volume changes in the ventricle, the device captures atrial event information through different physical dimensions that are accessible from the ventricular location
3Reliability
If the pacemaker uses multiple measurement modalities to detect atrial events, then the reliability of detection is improved, but the device complexity increases due to multiple measurement modules
Solution Approach 1:
The patent merges multiple measurement modalities (pressure sensing, acceleration sensing, electrogram sensing) into a single integrated leadless pacemaker device. All sensors and processing circuits are combined within the compact ventricular pacemaker housing, eliminating the need for separate sensing devices and leads while achieving reliable atrial event detection through multi-modal sensing
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A ventricularly implantable medical device that includes a sensing module that is configured to identify a search window of time within a cardiac cycle to search for an atrial artifact. Control circuitry in the ventricular implantable medical device is configured to deliver a ventricular pacing therapy to a patient's heart, wherein the ventricular pacing therapy is time dependent, at least in part, on an atrial event identified in the search window of time.